Insider Stock Trading History of Collins Morton


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Collins Morton since year 2005. The trader's CIK number is 1238716. At the time of this reporting, Collins Morton is the of Inovio Pharmaceuticals, Inc. . (stock ticker symbol INO). See this page for all insider trading activities at Inovio Pharmaceuticals, Inc. .

Note that in the past COLLINS MORTON also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Collins Morton since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-05-12 INO Inovio Pharmaceuticals, Inc. Option Ex 7,669 .00 0
2017-03-27 INO Inovio Pharmaceuticals, Inc. Buy 21,300 6.25 133,188
2016-06-28 INO Inovio Pharmaceuticals, Inc. Buy 10,000 9.13 91,310
2016-05-18 KOPN Kopin Corp Buy 56,500 1.88 106,220
2016-05-08 INO Inovio Pharmaceuticals, Inc. Option Ex 5,000 .00 0
2016-04-15 INO Inovio Pharmaceuticals, Inc. Buy 68,400 9.49 649,116
2014-08-21 INO Inovio Pharmaceuticals, Inc. Buy 8,000 10.01 80,088
2014-08-20 INO Inovio Pharmaceuticals, Inc. Buy 40,600 9.73 395,038
2013-11-13 INO Inovio Pharmaceuticals, Inc. Buy 254,500 1.82 463,190
2013-01-15 INO Inovio Pharmaceuticals, Inc. Buy 100,000 .67 66,900
2011-08-23 INO Inovio Pharmaceuticals, Inc. Buy 50,000 .66 32,800
2011-08-11 INO Inovio Pharmaceuticals, Inc. Buy 50,000 .63 31,500
2011-06-29 INO Inovio Pharmaceuticals, Inc. Buy 50,000 .59 29,300
2011-06-24 INO Inovio Pharmaceuticals, Inc. Buy 100,000 .58 57,599
2008-12-18 SDIX Standard Diversified Opportunities Inc. Sale 20,000 .81 16,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Collins Morton ( of Inovio Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.